New York, NY — March, 31 2026
Biolux Technology, a leader in light-accelerated orthodontics, today announced that OrthoPulse lite will be featured in the New Product Showcase Award Competition at the American Association of Orthodontists (AAO) 2026 Annual Session in Orlando, Florida.
OrthoPulse lite is an FDA-cleared near-infrared (NIR) light device designed to stimulate the biological processes behind tooth movement. By enhancing bone remodeling at the cellular level, it enables orthodontists to deliver faster, more predictable, and more comfortable treatments across aligners, fixed appliances, and hybrid protocols—with just 10 minutes of daily use.
A New Standard: Movement Assurance
At the core of OrthoPulse is a new clinical paradigm: movement assurance—helping teeth respond more efficiently to orthodontic forces and enabling treatment to track closer to plan. In aligner therapy, this translates into greater predictability, with clinical studies showing:
Up to 50% faster treatment time
35% fewer finishing aligners required
Up to 73% reduction in peak pain
Expanding Access to Light Therapy
With OrthoPulse lite, Biolux Technology expands access to its patented near-infrared technology—enabling orthodontists to integrate light therapy across all patients and treatment types, without changing their workflow. Participation in the AAO New Product Showcase reflects a broader shift in orthodontics toward biologically driven, technology-enabled care—where efficiency, predictability, and patient experience align.
Participating in the AAO New Product Showcase highlights the growing momentum behind OrthoPulse lite,” said Chuck Abra ham, CEO of Biolux Technology. “We are helping clinicians move beyond managing variability to delivering treatment as planned. Once you integrate OrthoPulse, there’s no going back.
Experience OrthoPulse at AAO 2026
Biolux Technology will showcase OrthoPulse lite at booth #1268. Attendees are invited to explore the science, review clinical outcomes, and see how light-accelerated orthodontics is advancing toward a new standard of care.
Book a live demo with our team and experience OrthoPulse in action:
About OrthoPulse
OrthoPulse is the pioneer in near-infrared photobiomodulation therapy for orthodontics and the only FDA-cleared device indicated as an adjunct to orthodontic treatment. With a growing global presence and regulatory approvals across major international markets, OrthoPulse supports improved efficiency, enhanced comfort, and predictable outcomes for both aligner and fixed appliance workflows.
Learn more at: www.orthopulse.com
Media Contact: Michael Hendricks
Chief Revenue Officer, Biolux Technology USA LLC